Anika Therapeutics Inc.
ANIK
Market Cap$374.57M
Close$
$21.95
14.3% downside
Current Fair Value
14.3% downsideOvervalued by 14.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $374.57 Million |
|---|---|
| Enterprise Value | $305.94 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-5.64 |
| Beta | 0.59 |
| Outstanding Shares | 14,828,456 |
| Avg 30 Day Volume | 56,995 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.53 |
|---|---|
| PEG | 8.04 |
| Price to Sales | 2.33 |
| Price to Book Ratio | 1.83 |
| Enterprise Value to Revenue | 1.81 |
| Enterprise Value to EBIT | -17.04 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Anika Therapeutics Inc.
CEO: Joseph Darling